BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16043746)

  • 21. Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery.
    Poitou C; Lacorte JM; Coupaye M; Bertrais S; Bedel JF; Lafon N; Bouillot JL; Galan P; Borson-Chazot F; Basdevant A; Coussieu C; Clément K
    Obes Surg; 2005 Jan; 15(1):11-23. PubMed ID: 15760495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects.
    Fernández-Real JM; Broch M; Vendrell J; Richart C; Ricart W
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1334-9. PubMed ID: 10720087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The significance of -174G/C polymorphism of the gene coding for interleukin-6 in neonatal infections].
    Wojsyk-Banaszak I; Seremak-Mrozikiewicz A; Szczapa J; Drews K; Zandecka-Dziubak J; Mrozikiewicz PM
    Ginekol Pol; 2005 Feb; 76(2):127-34. PubMed ID: 15847080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein.
    Vickers MA; Green FR; Terry C; Mayosi BM; Julier C; Lathrop M; Ratcliffe PJ; Watkins HC; Keavney B
    Cardiovasc Res; 2002 Mar; 53(4):1029-34. PubMed ID: 11922913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis.
    Carulli L; Canedi I; Rondinella S; Lombardini S; Ganazzi D; Fargion S; De Palma M; Lonardo A; Ricchi M; Bertolotti M; Carulli N; Loria P
    Dig Liver Dis; 2009 Nov; 41(11):823-8. PubMed ID: 19403348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Il6 gene promoter polymorphism (-174G/C) influences the association between fat mass and cardiovascular risk factors.
    Moleres A; Rendo-Urteaga T; Azcona C; Martínez JA; Gómez-Martínez S; Ruiz JR; Moreno LA; Marcos A; Marti A;
    J Physiol Biochem; 2009 Dec; 65(4):405-13. PubMed ID: 20358354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in mexican patients with rheumatoid arthritis: a case-control study.
    Zavaleta-Muñiz SA; Martín-Márquez BT; Gonzalez-Lopez L; Gonzalez-Montoya NG; Díaz-Toscano ML; Ponce-Guarneros JM; Ruiz-Padilla AJ; Vázquez-Del Mercado M; Maldonado-González M; Fafutis-Morris M; Flores-Martínez SE; Martínez-García EA; Gamez-Nava JI
    Clin Dev Immunol; 2013; 2013():959084. PubMed ID: 24223608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of interleukin (IL)-6 gene polymorphisms on recurrent aphthous stomatitis.
    Karakus N; Yigit S; Rustemoglu A; Kalkan G; Bozkurt N
    Arch Dermatol Res; 2014 Mar; 306(2):173-80. PubMed ID: 23982631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of Interleukin-6 (IL-6) Promoter Gene Polymorphisms (-174G>C, -572G>C, and -597G>A) on IL-6 Plasma Levels and Their Impact in the Development of Acute Ischemic Stroke in Young Indians.
    Akhter MS; Biswas A; Abdullah SM; Hobani Y; Ranjan R; Behari M; Saxena R
    Clin Appl Thromb Hemost; 2019; 25():1076029619854136. PubMed ID: 31215220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
    Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction.
    Revilla M; Obach V; Cervera A; Dávalos A; Castillo J; Chamorro A
    Neurosci Lett; 2002 May; 324(1):29-32. PubMed ID: 11983287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of interleukin 6 promoter polymorphisms (-174 G > C, -572 G > C and -597 G > A) on plasma IL-6 levels and their influence on the development of DVT: a study from India.
    Sharma A; Singh K; Biswas A; Ranjan R; Kishor K; Pandey H; Kumar R; Mahapatra M; Oldenburg J; Saxena R
    Hematology; 2018 Dec; 23(10):833-838. PubMed ID: 29890913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the promoter polymorphism IL-6 -174G/C in dermatomyositis and systemic lupus erythematosus.
    Hristova M; Dourmishev L; Kamenarska Z; Nikolova S; Kaneva R; Vinkov A; Baleva M; Monova D; Mitev V
    Biomed Res Int; 2013; 2013():315365. PubMed ID: 24106699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation.
    Bamoulid J; Courivaud C; Deschamps M; Mercier P; Ferrand C; Penfornis A; Tiberghien P; Chalopin JM; Saas P; Ducloux D
    J Am Soc Nephrol; 2006 Aug; 17(8):2333-40. PubMed ID: 16837641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.
    Zhai K; Yang Y; Gao ZG; Ding J
    Oncotarget; 2017 Jul; 8(27):44490-44497. PubMed ID: 28548958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men.
    Berthier MT; Paradis AM; Tchernof A; Bergeron J; Prud'homme D; Després JP; Vohl MC
    J Hum Genet; 2003; 48(1):14-9. PubMed ID: 12560873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
    DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
    Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Single Nucleotide Polymorphism
    Rodrigues APDS; Rosa LPS; da Silva HD; Silveira-Lacerda EP; Silveira EA
    J Obes; 2018; 2018():2743081. PubMed ID: 30652031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between single nucleotide polymorphisms in -174G/C and -634C/G promoter region of interleukin-6 and prostate cancer.
    Bao S; Yang W; Zhou S; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):693-6. PubMed ID: 19107369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.